AIKIDO PHARMA INC: Diferență între versiuni
Admin (discuție | contribuții) (Pagină nouă: Pagina dedicata companiei AIKIDO PHARMA INC listata cu simbolurile US.AIKI, US.AIKIc ==Descriere companie== AIkido Pharma Inc.(https://aikidopharma.com/), a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute mye...) |
(The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).) |
||
| Linia 1: | Linia 1: | ||
Pagina dedicata companiei AIKIDO PHARMA INC listata cu simbolurile US.AIKI, US.AIKIc | Pagina dedicata companiei AIKIDO [[PHARMA]] INC listata cu simbolurile US.AIKI, US.AIKIc | ||
==Descriere companie== | ==Descriere companie== | ||
Versiunea curentă din 29 septembrie 2024 03:40
Pagina dedicata companiei AIKIDO PHARMA INC listata cu simbolurile US.AIKI, US.AIKIc
Descriere companie[edit | ]
AIkido Pharma Inc.(https://aikidopharma.com/), a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The Company is also developing an antiviral platform that inhibits replication of multiple viruses, including influenza virus, SARS-CoV, MERS-CoV, Ebolavirus, and Marburg virus. It has a license agreement with the University of Texas; and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is based in New York, New York.
Grafic actiuni companie[edit | ]